-
Mashup Score: 20
A research team at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has succeeded in establishing a model of the blood-brain barrier using modularized tissue derived from human cells. …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 23
The White Blood Cell (WBC) count is one of the key parameters signaling the health of the immune system. Abnormal WBC counts often signal a systemic insult to the body such as an underlying infection or an adverse side effect to medication. Typically, the blood collected is sent to a central lab for testing, and results come back within hours, which is often inconvenient and may delay time-sensitive diagnosis or treatment. Here, we present the CytoTracker, a fully electronic, microfluidic based instant WBC analyzer with the potential to be used at point-of-care. The CytoTracker is a lightweight, portable, affordable platform capable of quantifying WBCs within minutes using only 50 μl of blood (approximately one drop of blood). In this study, we clinically evaluated the accuracy and performance of CytoTracker in measuring WBC and granulocyte counts. A total of 210 adult patients were recruited in the study. We validated the CytoTracker against a standard benchtop analyzer (Horiba Point
Source: journals.plos.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 18Role of inherited genetic variants in rare blood cancer uncovered - 4 month(s) ago
Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer.
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand - 5 month(s) ago
Nature Biomedical Engineering – A fluorescence-based assay that leverages the enzyme Cas12a to transduce and amplify cumulative forces generated by cells allows for the quantification of platelet…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0BD launches next-gen needle-free blood draw tech - 6 month(s) ago
BD announced today that it launched next-generation FDA-cleared needle-free blood draw technology.
Source: www.massdevice.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Education Program Improves Patient-Provider Communication | ASH Clinical News | American Society of Hematology - 9 month(s) ago
An educational program for patients with blood cancers and their caregivers was found to improve communication between both groups and their doctors, according to a study published in the Journal of Cancer Education. This single-arm, pre-post study used self-report surveys to assess the acceptability and impact of a training video for patients and caregivers. The training video was designed to model strategies for patient-provider communication using the PACES method and relay information about cancer
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.’s life. But many cancer researchers, wary of overtesting, argue it’s premature to prescribe the Galleri test w…
Source: kffhealthnews.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3In vivo hematopoietic stem cell modification by mRNA delivery - 9 month(s) ago
Targeting specific messenger RNA–encapsulating lipid nanoparticles to hematopoietic stem cells permits in vivo bone marrow transplantation.
Source: www.science.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Secretomics reveals gelatinase substrates at the blood-brain barrier that are implicated in astroglial barrier function - 9 month(s) ago
Focal cleavage of selected cell surface proteins on astroglial cells modulate brain vessel barrier function.
Source: www.science.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1FDA designates recall of troponin tests producing false-negative MI results as class I - 10 month(s) ago
The FDA announced that it has designated a recall of blood tests for cardiac troponin shown to produce false negatives for MI as class I, the most serious kind.On May 25, Quidel Cardiovascular Inc. recalled its cardiac panels (Quidel Triage Cardiac Panel; Quidel Triage Cardiac Panel, Troponin I; and Quidel Triage Cardiac Panel, CK-MB and Troponin I) after it received reports of inaccurate tests
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
Researchers model #blood-brainBarrier using 'Tissue-in-a-CUBE' system @riken_en @CommsBio https://t.co/xAOMZJGGr8